Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

Regular prophylactic intravenous infusion of factor VIII is the current treatment for persons with severe hemophilia A. However, because of the half-life of factor VIII, more than two infusions per week are necessary for maintaining protective trough levels, which results in a substantial treatment…

https://ift.tt/2wy9ObP